4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-023863
EVP, Chief Financial Officer sold 1,916 shares at $18.16 ($34,795)
- EVP, Chief Financial Officer acquired 5,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-04-05 | Option exercise | +5,275 | 9,393 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-04-06 | Sale | −1,916 | $18.16 | $34,795 | 7,477 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-04-05 | Option exercise · Restricted Stock Units | −5,275 | 15,826 | D | ||
| Open-market sales · 1,916 sh · avg $18.16 · $34,795 | |||||||
Loading xslF345X04/doc4.xml…